Showing results (71-80 of 149) with videos related to
Sort By:
Pageof 15
Oncotarget|December 1, 2016
Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patientsXiaoyan Liu, Jesse J Swen, Epie Boven, et al.Genes|February 25, 2023
Predictive Value of <i>SLCO1B1</i> c.521T>C Polymorphism on Observed Changes in the Treatment of 1136 Statin-UsersMarleen E Jansen, Tessel Rigter, Thom M C Fleur, et al.Journal of the American College of Cardiology|September 11, 2024
Genotype-Guided Antiplatelet Therapy: JACC Review Topic of the WeekWout W A van den Broek, Brenden S Ingraham, Naveen L Pereira, et al.Frontiers in Pharmacology|June 26, 2023
The impact of <i>CYP2C19</i> genotype on phenoconversion by concomitant medicationLaura M de Jong, Soukayna Boussallami, Elena Sánchez-López, et al.Clinical Pharmacokinetics|October 28, 2024
Changes in Plasma Clearance of CYP450 Probe Drugs May Not be Specific for Altered In Vivo Enzyme Activity Under (Patho)Physiological Conditions: How to Interpret Findings of Probe Cocktail StudiesLaura M de Jong, Marinda van de Kreeke, Mariam Ahmadi, et al.European Urology|May 2, 2015
CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinomaMeta H M Diekstra, Jesse J Swen, Epie Boven, et al.Genes|November 30, 2018
Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD VariantsCarin A T C Lunenburg, Linda M Henricks, André B P van Kuilenburg, et al.Clinical Pharmacology and Therapeutics|May 1, 2019
Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic TestingCathelijne H van der Wouden, Mandy H van Rhenen, Wafa O M Jama, et al.Genes|December 3, 2020
Using Personal Genomic Data within Primary Care: A Bioinformatics Approach to PharmacogenomicsRick Overkleeft, Judith Tommel, Andrea W M Evers, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2022
Increased Tacrolimus Exposure in Kidney Transplant Recipients With COVID-19: Inflammation-Driven Downregulation of Metabolism as a Potential MechanismSylvia D Klomp, Soufian Meziyerh, Maurits F J M Vissers, et al.Pageof 15